Parisa Emami-Naeini, MD, MPH, Vincent Garmo, MHS, Nick Boucher, BSc, Rusirini Fernando, BSc, Alicia Menezes, MD. “Maintenance of Vision Needed to Drive after Intravitreal Anti-VEGF Therapy in Patients with Neovascular AMD and Diabetic Macular Edema”. American Academy of Ophthalmology (AAO), October 2023. Research Article
Damla Oncel, BS, and Samuel Minaker, MD, MSc. “Smoking Increases Proliferative Vitreoretinopathy Risk in Retinal Detachment”. Ophthalmology Advisor, Presented at American Society of Retina Specialists (ASRS) 41st Annual Meeting; July 28-August 1, 2023; Seattle. Poster
Ella H. Leung, MD, Henry A. Leder, MD, Shriji Patel, MD, MBA, Rahul Reddy, MD, Nick Boucher, BSc, Chakshu Sharma, MEng, Jill Blim, MS, Carl Awh, MD, FASRS, and Paul Hahn, MD, PhD, FASRS. “Opportunity Cost of Retinal Detachment Surgery vs Office-Based Patient Care“. American Society of Retina Specialists (ASRS), July 2022. Journal
Matthew R. Starr, MD, David Xu, MD, Nicholas Boucher, Namrata Saroj, OD, Luv G. Patel, MD, Michael Ammar, MD, Ravi R. Pandit, MD, Thomas L. Jenkins, MD, and Allen C. Ho, MD. “Characterizing Progression to Neovascular AMD in Fellow Eyes of Patients Treated With Intravitreal Anti-VEGF Injections”. Ophthalmic Surgery, Lasers and Imaging Retina, March 2021;52(3):123–128. Journal
Tatiana R. Rosenblatt, Daniel Vail, Namrata Saroj, OD, Nick Boucher, Darius M. Moshfeghi, MD, and Andrew A. Moshfeghi, MD, MBA. “Increasing Incidence and Prevalence of Common Retinal Diseases in Retina Practices Across the United States.” Ophthalmic Surgery, Ophthalmic Surgery, Lasers and Imaging Retina, January 2021;52(1):29–36. Journal
John S. Pollack, MD, David D. Williams, MD, MBA, Tom Brogan, BA, Nick Boucher, BSc, Nitika Aggarwal, BSc. “Tracking the Impact of COVID-19 on the Retina Community – Part 2”. Retina Times, Published by the American Society of Retina Specialists (ASRS), October 2020. Article
John D. Pitcher, III, MD, Andrew A. Moshfeghi, MD, MBA, Genevieve Lucas, B Comm, Nick Boucher, BS, Hadi Moini, PhD and Namrata Saroj, OD. “Evaluation of Patients Receiving Intravitreal Antivascular Endothelial Growth Factor for Diabetic Macular Edema in Clinical Practice in the United States“. VitreoRetinal Journal, September 2020, Journal
Tatiana Rosenblatt, Daniel Vail, Namrata Saroj, Nick Boucher, Darius Moshfeghi, Andrew A Moshfeghi. “Epidemiology of common retinal diseases in retina practices in the United States“. Investigative Ophthalmology & Visual Science, Vol.61, June 2020. Abstract
Tatiana Rosenblatt, Daniel Vail, Namrata Saroj, Nick Boucher, Darius Moshfeghi, Andrew A Moshfeghi. “AMD, DED most common retinal conditions in the United States“. Modern Retina, from Ophthalmology Times, August 2020. Article
Luo, “The progression of retinal disease in eyes of patients lost to follow-up for at least 6 months”. Retina Society, July, 2020, Presentation
Thomas A. Ciulla, MD, John S. Pollack, MD, David D. Williams, MD. “Mean 1-Year Visual Acuity Change in Retinal Vein Occlusion Related Macular Edema Correlates with Anti-VEGF Treatment Intensity: An Analysis of 12,214 Eyes”. American Academy of Ophthalmology (AAO), March 2020. Paper
Thomas A. Ciulla, MD, MBA, John S. Pollack, MD, David D. Williams, MD, MBA. “Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Macular Edema Due to Retinal Vein Occlusion: An Analysis of 12,214 Eyes“. Retina Society, March 2020. Paper
John S. Pollack, MD, David D. Williams, MD, MBA, Tom Brogan, BA, Nick Boucher, BSc, Nitika Aggarwal, BSc. “Tracking the Impact of COVID-19 on the Retina Community – Part 1”. Retina Times, Published by the American Society of Retina Specialists (ASRS), March 2020. Article
Michael Singer, MD, Dilsher Dhoot, MD. “Review of Intravitreal Injections and Endophthalmitis“. Retinal Physician, February 2020. Newsletter
Thomas A. Ciulla, MD, MBA, Rehan M. Hussain, MD, John S. Pollack, MD, David D. Williams, MD, MBA. “Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients: A Real-World Analysis of 49, 485 Eyes”. Ophthalmology Retina Volume 4, Number 1, January 2020. Journal
Andrew P. Schachat, MD. “Ophthalmology Retina Enters Year 4: Some comments on Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema”. Ophthalmology Retina Volume 4, Number 1, January 2020. Editorial.
Karen Appold.“NEW PRODUCT APPLICATIONS: Data Analytics Give Retinal Physicians an Edge”. Retinal Physician, Volume: 16, Issue: November/December 2019, page(s): 50, 51. Article
Susan Worley. “Big Data, Analytics, and AI in Retina Practice”. Retinal Physician, Volume: 16, Issue: November/December 2019, page(s): E1-E8. Article
Arshad M. Khanani, MD, MA, Adrian Skelly, MSc, MBA, Vladimir Bezlyak, PhD, Ray Griner, MPH, Laura Rodriguez Torres, MSc, Alexandros Sagkriotis, MSc. “SIERRA-AMD: A Retrospective, Real-World Evidence Study of Patients with Neovascular Age-Related Macular Degeneration in the United States”. Ophthalmology Retina, September 2019. Paper
Andrew P. Schachat, MD. “Real-World Papers, Prophylaxis for Intravitreal Injections, Fluorescein Angiography and Neovascular Age-Related Macular Degeneration, and Anti-Vascular Endothelial Growth Factor Safety”. Ophthalmology Retina, July 2018. Editorial
Kevin Kunzmann. “Real-World Analysis Supports More Frequent Anti-VEGF Dosing for First-Year nAMD”. HCP Live, July 2018. Presentation
Thomas A. Ciulla, MD, MBA, Peter Bracha, MD, John Pollack, MD, David F. Williams, MD, MBA. “Real-world Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States”. Ophthalmology Retina, April 2018. Editorial
Thomas A. Ciulla, MD, MBA, Forbes Huang, Keith Westby, MBA, David F. Williams, MD, MBA, Sandi Zaveri, RPh, Samir C. Patel, MD. “Real-world Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration in the United States”. American Academy of Ophthalmology (AAO), February 2018. Article